Fig. 4From: Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve diseaseChange in serum ESM-1 concentration before and after the drug change. Serum ESM-1 concentrations decreased and clinical signs resolved in all patients with increased cardiovascular drug dose (n = 5) (p = 0.0695). Abbreviations: ESM-1, endothelial cell-specific molecule-1Back to article page